|
MESDC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.42830000002559E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.77949999980687E-07 |
| Normal-vs-Stage2 |
5.303600E-03 |
| Normal-vs-Stage3 |
3.811500E-02 |
| Normal-vs-Stage4 |
1.297660E-02 |
| Stage1-vs-Stage2 |
7.223200E-01 |
| Stage1-vs-Stage3 |
2.106000E-02 |
| Stage1-vs-Stage4 |
4.121600E-01 |
| Stage2-vs-Stage3 |
2.431400E-01 |
| Stage2-vs-Stage4 |
7.439800E-01 |
| Stage3-vs-Stage4 |
4.070400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.28879999997211E-06 |
| Normal-vs-AfricanAmerican |
8.510000E-02 |
| Normal-vs-Asian |
7.851900E-02 |
| Caucasian-vs-AfricanAmerican |
5.244300E-02 |
| Caucasian-vs-Asian |
9.438600E-01 |
| AfricanAmerican-vs-Asian |
4.125400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.795330E-04 |
| Normal-vs-Female |
9.79540000001222E-07 |
| Male-vs-Female |
8.550000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.033000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.40809999999936E-05 |
| Normal-vs-Age(61-80Yrs) |
1.73105999999867E-05 |
| Normal-vs-Age(81-100Yrs) |
1.256200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.162400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.204200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.578400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.236600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.068000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.595400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.002900E-03 |
| Normal-vs-Grade 2 |
6.85579999992747E-07 |
| Normal-vs-Grade 3 |
1.817380E-03 |
| Normal-vs-Grade 4 |
2.598300E-02 |
| Grade 1-vs-Grade 2 |
8.916000E-01 |
| Grade 1-vs-Grade 3 |
2.030200E-01 |
| Grade 1-vs-Grade 4 |
2.580400E-01 |
| Grade 2-vs-Grade 3 |
4.923900E-02 |
| Grade 2-vs-Grade 4 |
1.742630E-01 |
| Grade 3-vs-Grade 4 |
9.559400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.17350000050642E-07 |
| Normal-vs-ccB subtype |
2.275300E-03 |
| ccA subtype-vs-ccB subtype |
1.180400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.18980000000247E-05 |
| Normal-vs-N1 |
1.927450E-01 |
| N0-vs-N1 |
8.703800E-01 |
|
|
